Why Manufacturers Get the Best COGS Position Under 280E
Section 280E blocks ordinary deductions for any trade or business trafficking in a Schedule I substance, but it can't reach cost of goods sold. A reseller's COGS stops at invoice price plus acquisition cost. A producer, under Sections 471 and 263A, gets to capitalize direct materials, direct labor and a defined set of indirect production costs into inventory and recover them through COGS as finished units sell.
An Illinois infuser running volatile extraction recovers solvent cost, extraction technician wages and payroll tax, lab consumables, equipment depreciation, the utilities running the closed-loop system, C1D1 booth occupancy, in-process QC and genuine production-supervisory time. The identical dollar spent by a dispensary would be lost entirely. That's not a loophole — it's ordinary inventory accounting — but it only survives examination when the cost accounting behind it is real.
The flip side matters just as much: selling, marketing, brand and executive costs stay out of the production pool. Manufacturers who sweep everything into inventory invite adjustment and end up losing the legitimate positions along with the illegitimate ones. Discipline in both directions is what makes the position defensible.
- Direct materials: biomass, distillate, terpenes, solvents, hardware, packaging
- Direct labor: extraction, infusion, filling and packaging wages plus burden
- Indirect production: depreciation, production utilities, QA, square-footage facility cost
- Excluded: sales commissions, brand marketing, executive pay, investor relations
Bills of Materials and Standard Costing
Every SKU needs a bill of materials that reflects reality: grams of input biomass, expected extraction yield, refinement passes, terpene and diluent inputs, cartridge hardware, child-resistant packaging, label stock and labor minutes at each station. Once that exists, a standard cost per unit can be set and every period's actual spend measured against it.
Standard costing is what turns a general ledger into an actual management tool. When a 1g cartridge run's actual cost diverges from standard, the variance breaks into an input price variance, a biomass usage variance, an extraction yield variance and a fill-line labor efficiency variance — each with a different owner and a different fix. Without a standard, all you see is margin that moved for no clear reason.
For tax purposes, the standard cost model still has to reconcile to actual cost at period end. We revalue inventory, clear variance accounts into COGS and inventory on a rational basis, and document the method so it applies consistently year after year.
Yield Accounting
Yield drives extraction economics more than anything else. Going from a 9 percent to a 12 percent crude yield on the same biomass changes cost per gram by roughly a third. We track yield by lot, input strain and operator, and tie the measurement to BioTrack package weights instead of floor estimates, so the number driving cost is the same number the state already has.
Loss needs its own treatment too. Normal spoilage stays in inventory cost, absorbed by good units. Abnormal spoilage — a failed run, a contaminated batch, a destruction event — gets expensed in the period, and under 280E that expense is worth far less than a capitalized cost. Process control has a direct tax consequence.
Conversion Cost Pools and Allocation
Conversion cost — everything spent turning raw material into finished goods — gets pooled and allocated on a driver that reflects reality: machine hours for extraction, labor hours for infusion and hand-packing, unit counts for filling. We document the driver choice, retain the supporting activity data, and revisit the basis when the production mix shifts.
Facility cost gets allocated by measured square footage: extraction rooms, kitchens, packaging areas and cold storage count as production space; the sales office and lobby don't. A floor plan with actual measurements in the workpapers turns a soft judgment call into something supportable.
BioTrack, Package Genealogy and Inventory Integrity
BioTrackTHC records manufacturing as a chain of package transformations — input packages consumed, a production batch created, output packages generated with new tags. Financial inventory has to mirror that chain: cost of consumed inputs flows into work in process, conversion cost gets added, and finished package cost settles when output tags are created.
When the ledger and BioTrack drift — and they always drift when nobody's watching — the gap is either a costing error or a compliance error, and either one is expensive. We reconcile package-level quantities to the perpetual inventory subledger monthly, investigate variances by lot, and document adjustments with the operational reason attached.
This reconciliation is also the backbone of an audit response. An examiner asking how ending inventory was calculated gets a package-level trail from state records to subledger to trial balance instead of a spreadsheet assembled after the fact.
- Monthly BioTrack-to-subledger reconciliation at package and lot level
- Work-in-process valuation for batches still open at period end
- Documented treatment of normal versus abnormal loss
- Destruction and waste events tied to both compliance logs and the ledger
Illinois-Specific Manufacturing Issues
Illinois taxes infused products at 20% under the Cannabis Purchaser Excise Tax, above the 10% rate for flower and other products at or under 35% THC, and higher still above 35% THC. That potency-tiered structure has to map correctly at the point of sale, and an infuser's wholesale pricing conversation with a dispensary needs to account for how the customer-facing tax on the finished product compares to flower, since it changes what the market will bear.
On top of the excise tax the retailer collects, infuser organizations and craft growers remit the 7% Cultivation Privilege Tax on gross receipts from sales into a dispensing organization, paid monthly to IDOR. That's an input cost the manufacturer bears directly and needs to model into margin, unlike the excise tax the dispensary collects from the end customer.
Social equity ownership is a factor too. Many Illinois infuser and craft grower licenses went to Social Equity Applicants with investor or management-services agreements layered on top, often carrying ownership-percentage covenants and equity-dilution limits that affect how intercompany fees and profit splits get structured and reported. Illinois also decoupled from 280E at the state level for tax years beginning on or after January 1, 2023, under Public Act 103-0592, so the state return deducts what the federal return disallows, subject to confirming current-year applicability. For manufacturers this creates large, permanent book-to-tax differences that need deliberate tracking rather than a reconstruction at filing.
Reporting a Manufacturer Can Actually Run On
The monthly package we build for manufacturing clients leads with cost per unit by SKU against standard, gross margin by product line, yield by lot and operator, and capacity utilization on the constrained asset. Those four numbers answer nearly every operating question: what to make, what to reprice, what to discontinue, and where the next dollar of capital should go.
Underneath that sits the tax view: inventoriable cost captured for the period, the effective federal rate implied by current gross margin, and the cash tax forecast. Manufacturers who see the tax impact of a pricing or mix decision in the same report as the operating result make noticeably better calls than those who find out in the spring.
